Folic%2525252520acid

# Folic Acid ## Overview Folic acid (vitamin B9) is a water-soluble B vitamin essential for DNA synthesis, repair, and erythropoiesis. Exogenous supplementation is required as humans cannot synthesize folate. ## Primary Indications * Prevention and treatment of folate deficiency anemia. * Prevention of neural tube defects (NTDs) in pregnancy. * Prophylaxis in patients on long-term methotrexate or chronic hemolytic anemias (e.g., sickle cell, thalassemia). ## Adult Dosing * **Folate Deficiency:** 1 mg daily (range 1–5 mg/day) until hematologic recovery. * **Pregnancy (Prevention of NTDs):** 400 mcg–800 mcg daily, starting at least 1 month before conception and through the first trimester. High-risk patients (history of NTDs or anti-epileptic use) may require 4–5 mg daily. * **Methotrexate Supplementation:** 1–5 mg daily (non-MTX days) to mitigate hematologic/GI side effects. ## Pediatric Dosing * **Deficiency/Anemia:** * Infants: 0.1 mg daily. * Children/Adolescents: 0.5–1 mg daily. * **Chronic Hemolytic Anemia:** 0.1–1 mg daily (depending on age and clinical protocol). * **Maintenance:** 0.1 mg daily. ## Dose Adjustments * **Renal/Hepatic:** No standardized dosage adjustments required for renal or hepatic impairment. * **General Note:** Dosages above 1 mg/day may mask the diagnosis of Vitamin B12 deficiency; ensure B12 status is evaluated if macrocytic anemia persists. ## Contraindications * Hypersensitivity to folic acid. * Undiagnosed anemia (specifically pernicious anemia or B12 deficiency anemia), as folic acid may correct the hematologic manifestations but allow neurological damage to progress. ## Adverse Effects * Generally well-tolerated. * Rare: Allergic reactions (rash, pruritus, bronchospasm), GI upset, abdominal pain, or sleep disturbances at very high doses. ## Key Drug Interactions * **Methotrexate:** Folic acid may decrease the efficacy of methotrexate; dosing should be separated (avoid taking on the same day as MTX). * **Anticonvulsants (Phenytoin, Carbamazepine, Valproate):** May decrease serum folate levels; supplementation may also lower serum concentrations of phenytoin. * **Sulfasalazine:** Inhibits intestinal absorption of folate. ## Monitoring * **Efficacy:** Hemoglobin, hematocrit, and red cell indices (MCV). * **Safety:** Serum Vitamin B12 levels in patients requiring prolonged or high-dose supplementation to prevent masking of B12 deficiency. ## Clinical Pearls * Therapy is ineffective for B12 deficiency anemia. Always exclude B12 deficiency before initiating high-dose folate therapy. * High-dose folate does not increase the risk of toxicity, but it is unnecessary unless specific clinical indications (e.g., malabsorption, high-dose MTX) are present. * Dosing varies significantly by institutional protocol (e.g., specific protocols for pregnancy vs. drug-induced deficiency); always verify against local guidelines. *** **Educational Disclaimer:** This information is for educational purposes only. Clinical practice guidelines and drug information evolve; always verify current prescribing information, dosing, and contraindications through institutional resources (e.g., Lexicomp, Micromedex) or professional clinical pharmacists before administration.